The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.
Clinical trial NCT06994286 · COMPLETED
Trial details
- NCT number
- NCT06994286
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-24
- Primary completion
- 2025-07-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.